Cargando…
T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b
OBJECTIVES: The evaluations of the pathogenetic roles of cell mediated immunity and of the preventive effect for disease progression with interferon(IFN) treatment in patients with chronic active hepatitis-B(CAH-B) are the objectives of this study. METHODS: Thirty-two patients with CAH-B were treate...
Autores principales: | Im, Euyi Hyeok, Sung, Jae Kyu, Lee, Sang Ou, Lee, Kyung Tae, Lee, Seung Min, Kim, Seok Hyun, Lee, Byung Seok, Seo, Kwang Sik, Kim, Seong Gul, Kim, Jin Hee, Kim, Nam Jae, Lee, Heon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531910/ https://www.ncbi.nlm.nih.gov/pubmed/10063307 http://dx.doi.org/10.3904/kjim.1999.14.1.1 |
Ejemplares similares
-
Colonoscopic withdrawal time and adenoma detection in the right colon
por: Yun, Gee Young, et al.
Publicado: (2018) -
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
por: You, Byung Chul, et al.
Publicado: (2012) -
Effect of Short-Term Prednisolone Therapy in Patients With Severe Chronic Type B Hepatitis
por: Yoo, Jae Young, et al.
Publicado: (1989) -
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study
por: Chon, Young Eun, et al.
Publicado: (2016) -
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
por: Lim, Jae Hee, et al.
Publicado: (2011)